All review series

Review series

Update on HER-2 as a target for cancer therapy

Review    
Update on HER-2 as a target for cancer therapy: Herceptin in the clinical setting
David W Miles
Breast Cancer Res 2001, 3:380-384 (11 October 2001)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

Review    
Intracellular signaling pathways of ErbB2/HER-2 and family members
Monilola A Olayioye
Breast Cancer Res 2001, 3:385-389 (4 October 2001)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

Review    
Update on HER-2 as a target for cancer therapy: Alternative strategies for targeting the epidermal growth factor system in cancer
William J Gullick
Breast Cancer Res 2001, 3:390-394 (1 October 2001)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

Review    
Update on HER-2 as a target for cancer therapy: The ERBB2 promoter and its exploitation for cancer treatment
Helen C Hurst
Breast Cancer Res 2001, 3:395-398 (1 October 2001)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

Review    
Update on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition
Isabel Correa, Tim Plunkett
Breast Cancer Res 2001, 3:399-403 (20 September 2001)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]